Furthermore we analyzed ALR and FOXA2 (HNF3β), a transcriptional regulator of ALR expression, in liver samples of a high fat diet mouse model and patients with hepatosteatosis or NASH. This evidence concerns the gene FOXA2 and metabolic dysfunction-associated steatohepatitis.